Courses & Units

Advanced Pharmacotherapeutics in Cardiovascular Diseases CSA722


CSA722 is a self-directed, fully on-line unit, that explores a variety of disease states and their management, using a series of patient cases linked to assignment based questions, to enable the student to enhance their knowledge in the area of clinical pharmacy and pharmaceutical care.


Unit name Advanced Pharmacotherapeutics in Cardiovascular Diseases
Unit code CSA722
Credit points 12.5
College/School College of Health and Medicine
School of Pharmacy and Pharmacology
Discipline Pharmacy
Coordinator Doctor Mohammed Salahudeen
Teaching staff Miss Jacqueline Martin
Delivered By University of Tasmania
Level Postgraduate


Location Study period Attendance options Available to
Hobart Semester 1 Off-Campus International Domestic
Hobart Semester 2 Off-Campus International Domestic


International students
Domestic students

Key Dates

Study Period Start date Census date WW date End date
Semester 1 21/2/2022 22/3/2022 11/4/2022 29/5/2022
Semester 2 11/7/2022 9/8/2022 29/8/2022 16/10/2022

* The Final WW Date is the final date from which you can withdraw from the unit without academic penalty, however you will still incur a financial liability (refer to How do I withdraw from a unit? for more information).

Unit census dates currently displaying for 2022 are indicative and subject to change. Finalised census dates for 2022 will be available from the 1st October 2021. Note census date cutoff is 11.59pm AEST (AEDT during October to March).

About Census Dates

Learning Outcomes

  • Identify and evaluate problems associated with cardiovascular medicines using an evidence-based approach.
  • Critically evaluate cardiovascular medication therapy using an evidence-based approach and accepted best clinical practice to devise and justify appropriate courses of action for therapeutic management.
  • Employ evidence-based and contemporary clinical skills to conduct a clinical audit and demonstrate how this may influence pharmacy practice in the management of cardiovascular disease.
  • Demonstrate effective written and oral presentation skills to explain contemporary issues associated with cardiovascular medication therapy

Fee Information

Field of Education Commencing Student Contribution 1,3 Grandfathered Student Contribution 1,3 Approved Pathway Course Student Contribution 2,3 Domestic Full Fee 4
019907 $1,002.00 $1,002.00 not applicable $2,354.00

1 Please refer to more information on student contribution amounts.
2 Please refer to more information on eligibility and Approved Pathway courses.
3 Please refer to more information on eligibility for HECS-HELP.
4 Please refer to more information on eligibility for FEE-HELP.

If you have any questions in relation to the fees, please contact UConnect or more information is available on StudyAssist.

Please note: international students should refer to What is an indicative Fee? to get an indicative course cost.


Concurrent Prerequisites



Teaching Pattern

Online via MyLO and Online tutorial and meeting rooms.

AssessmentQuiz (5%)|Assignment 4 - Presentation (20%)|Assignment 1 - Evidence-based response (15%)|Assignment 2 - Short clinical case (25%)|Assignment 3 - Long clinical case (35%)
TimetableView the lecture timetable | View the full unit timetable



Required readings will be listed in the unit outline prior to the start of classes.

LinksBooktopia textbook finder

The University reserves the right to amend or remove courses and unit availabilities, as appropriate.